167 related articles for article (PubMed ID: 20425677)
1. [Immunological intervention to preserve beta-cell function in type 1 diabetes].
Schloot NC
Dtsch Med Wochenschr; 2010 May; 135(18):915-21. PubMed ID: 20425677
[TBL] [Abstract][Full Text] [Related]
2. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
3. [(Auto)immunological aspects of type 1 diabetes mellitus].
Dieterle C
MMW Fortschr Med; 2006 Apr; 148(16):36-9; quiz 40. PubMed ID: 16688947
[TBL] [Abstract][Full Text] [Related]
4. An update on preventive and regenerative therapies in diabetes mellitus.
Reimann M; Bonifacio E; Solimena M; Schwarz PE; Ludwig B; Hanefeld M; Bornstein SR
Pharmacol Ther; 2009 Mar; 121(3):317-31. PubMed ID: 19168093
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in the treatment of type 1 diabetes mellitus].
Schloot NC; Roden M; Bornstein SR; Brendel MD
Dtsch Med Wochenschr; 2011 Feb; 136(5):172-5. PubMed ID: 21271474
[TBL] [Abstract][Full Text] [Related]
6. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
7. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
8. The anti-interleukin-1 in type 1 diabetes action trial--background and rationale.
Pickersgill LM; Mandrup-Poulsen TR
Diabetes Metab Res Rev; 2009 May; 25(4):321-4. PubMed ID: 19405081
[TBL] [Abstract][Full Text] [Related]
9. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.
Waldron-Lynch F; Herold KC
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):303-17, viii. PubMed ID: 19328413
[TBL] [Abstract][Full Text] [Related]
10. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in type 1 diabetes.
Taplin CE; Barker JM
Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
[TBL] [Abstract][Full Text] [Related]
12. Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Verh K Acad Geneeskd Belg; 2008; 70(2):85-103. PubMed ID: 18630722
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes--the PRODIA study.
Ljungberg M; Korpela R; Ilonen J; Ludvigsson J; Vaarala O
Ann N Y Acad Sci; 2006 Oct; 1079():360-4. PubMed ID: 17130579
[TBL] [Abstract][Full Text] [Related]
14. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes - an update.
Fischer B; Elias D; Bretzel RG; Linn T
Expert Opin Biol Ther; 2010 Feb; 10(2):265-72. PubMed ID: 20034363
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in diabetes mellitus: current utility and perspectives.
Isermann B; Ritzel R; Zorn M; Schilling T; Nawroth PP
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):483-90. PubMed ID: 17853330
[TBL] [Abstract][Full Text] [Related]
17. Immunological disorders of type 1 diabetes mellitus.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
[TBL] [Abstract][Full Text] [Related]
18. Drug insight: New immunomodulatory therapies in type 1 diabetes.
Cernea S; Herold KC
Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):89-98. PubMed ID: 16932263
[TBL] [Abstract][Full Text] [Related]
19. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
Eldor R; Cohen IR; Raz I
Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
[TBL] [Abstract][Full Text] [Related]
20. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.
Keskinen P; Korhonen S; Kupila A; Veijola R; Erkkilä S; Savolainen H; Arvilommi P; Simell T; Ilonen J; Knip M; Simell O
Diabetologia; 2002 Dec; 45(12):1639-48. PubMed ID: 12488953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
